Resource

 

 

 

 

 

 

 

 

 

 

 

M&A: Acquiror's Counsel

Baker & McKenzie and DLA Piper advise on Accenture's Acquisition of Boomerang Pharmaceutical Communications

13 Jan 2016

Paris, January 4, 2016 – Baker & McKenzie advised Accenture on the acquisition of Boomerang Pharmaceutical Communications.  The e-marketing agency was represented by DLA Piper.

With this acquisition, Accenture has reinforced its expertise in e-consulting and e-marketing with its clients operating in the pharmaceutical, biotechnologies and medical instruments sectors, specifically in Europe.  As a result, Accenture now has new skills for the development and promotion of digital campaigns, web content and marketing operations.

Olswang advises All3Media on acquisition of New Pictures Limited

12 Jan 2016

Olswang has advised All3Media, the leading independent television, film and digital production and distribution company, on its acquisition of acclaimed drama production company New Pictures Limited.

The New Pictures team have enjoyed success with hit returning drama series The Missing and Indian Summers, and have had two new thriller series Rellik and Requiem commissioned by BBC One.

Stibbe advises Gimv

12 Jan 2016

Stibbe advises Gimv on its acquisition of a majority stake in the newly merged group Itho Daalderop and Klimaatgarant. This is one of Gimv's larger investments in the Netherlands.

Key Contact

Bjorn van der Klip

Litorina partners with CarpetVista

11 Jan 2016

Litorina IV L.P. (Litorina IV) has become the new majority owner of CarpetVista AB (CarpetVista). CarpetVista is one of the world's largest online carpet shops, offering more than 35 000 unique carpets. The company was previously wholly owned by its founders, who will retain ownership following the transaction.

Carpetvista was founded in Malmö 2005 and has an annual turnover of approximately SEK 200 million.

Sumitomo Dainippon Pharma to acquire Tolero Pharmaceuticals, Inc. for $780 million

10 Jan 2016

Jones Day is advising Sumitomo Dainippon Pharma Co. Ltd. in its acquisition of Tolero Pharmaceuticals, Inc. by Dainippon Sumitomo Pharma America Holdings, Inc., Sumitomo Dainippon Pharma's U.S. subsidiary, for up to $780 million. Sumitomo Dainippon Pharma will make an upfront payment of $200 million to the shareholders of Tolero on closing of the acquisition, and thereafter it will make development milestone payments up to $430 million related to the compounds being developed by Tolero based on its progress.

Eversheds LLP advises on strategic food manufacturing acquisition

08 Jan 2016

Eversheds LLP has advised Go2 Foods Limited, the latest venture from Glisten Plc founder and former CEO, Paul Simmonds, on the acquisition of The Real Yorkshire Pudding Co Limited.

 Formed in 1991, The Real Yorkshire Pudding Company is a leading manufacturer of chilled Yorkshire puddings and supplies many of the major food retailers and national wholesalers.  Recent developments include introducing a popular gluten free range, which includes both Yorkshire puddings and toad in the hole.

White & Case Advises Panasonic on US$1.545 Billion Acquisition of Hussmann Corporation

08 Jan 2016

White & Case LLP advised Panasonic Corporation in its US$1.545 billion acquisition of Hussmann Corporation, a Missouri-based manufacturer of refrigerated display cases and systems.

Panasonic agreed with Hussmann Parent Inc., the parent company of Hussmann Corporation, and private equity firm Clayton Dubilier & Rice, the representative of shareholders of Hussmann Parent, to buy 100% of the shares of Hussmann Parent. Hussmann Parent will become a wholly-owned subsidiary of Panasonic. 

The Carlyle Group Enters Into Exclusive Discussions with Astorg To Acquire A Majority Stake In Saverglass

08 Jan 2016

Paul Hastings has advised Astorg as global alternative asset manager The Carlyle Group today announced it has entered into exclusive discussions with Astorg to acquire a majority controlling stake in high-end glass packaging manufacturer Saverglass, alongside the Management.

Baker & McKenzie advises Chinese investor on public takeover offer for Medisana AG

08 Jan 2016

Baker & McKenzie advises Xiamen Comfort Science & Technology Group Co., Ltd. on its voluntary public takeover offer to the shareholders of Medisana AG.

Comfort Enterprise (Germany) GmbH, an asset management company, which is directly controlled by Xiamen Comfort Science & Technology Group Co., Ltd., decided on December 18, 2015, to make a cash offer to acquire the shares of Medisana AG, one of Germany's leading consumer healthcare products companies, by means of a voluntary public offering.